title: Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
abstract: We have studied the regulation by estradiol of the mannose-6-phosphate (Man-6-P)/insulin-like growth factor-II (IGF-II) receptor concentration in different breast cancer cell lines. The mRNA level was assayed by Northern blot using the H5.1 cDNA probe. The protein level was assayed by Western ligand blot, by binding saturation with [125I]procathepsin-D on total membrane preparations, and by immunoprecipitation of 35S-labeled proteins. In three estrogen receptor-positive cell lines (MCF7, T47D, and ZR75-1), estradiol specifically decreased the steady state level of the Man-6-P/IGF-II receptor protein and mRNA. Moreover, in different cell lines and in primary culture of normal mammary cells, the secretion of procathepsin-D was inversely correlated with the level of Man-6-P/IGF-II receptor protein and mRNA. We conclude that estradiol down-regulates the Man-6-P/IGF-II receptor in breast cancer cells. Since two of its ligands, procathepsin-D and IGF-II, are induced by estrogen, we propose that the Man-6-P/IGF-II receptor becomes saturated after estrogen treatment. This model might explain the previously described estrogen-induced secretion of procathepsin-D and other lysosomal proenzymes routed by the same transport system.
authors.affiliation: Unité Hormones et Cancer (U 148) Montpellier, France.
authors.forename: M
authors.initials: M
authors.lastname: Mathieu
authors.forename: F
authors.initials: F
authors.lastname: Vignon
authors.forename: F
authors.initials: F
authors.lastname: Capony
authors.forename: H
authors.initials: H
authors.lastname: Rochefort
mesh_terms: D001943:Breast Neoplasms; D002402:Cathepsin D / Q000096:biosynthesis*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction; D004792:Enzyme Precursors / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D007700:Kinetics; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology*; D008360:Mannosephosphates / Q000378:metabolism; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface / Q000235:genetics*; D017451:Receptors, Somatomedin; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D004792:Enzyme Precursors; D008360:Mannosephosphates; D012333:RNA, Messenger; D017527:Receptor, IGF Type 2; D011956:Receptors, Cell Surface; D017451:Receptors, Somatomedin; D004958:Estradiol; D007335:Insulin-Like Growth Factor II; D002402:Cathepsin D